Oncorus

The new 17,000 SF facility houses an open office work environment, multiple huddle and conference rooms, a café to serve as all-hand meeting area as well as an after-hours fun area, and BL1, BL2, and other critical research areas. The team leveraged base building infrastructure and augmented where appropriate to achieve redundancy requirements. Oncorus now has a headquarters where they can continue to develop a next-generation immunotherapy platform to treat cancer.

<< Return To News